These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

410 related articles for article (PubMed ID: 9562276)

  • 1. Changes in thyroid function and immunological parameters long after subtotal thyroidectomy for Graves' disease.
    Kasuga Y; Kobayashi S; Fujimori M; Shingu K; Asanuma K; Hama Y; Ito K; Maruyama M; Amano J
    Eur J Surg; 1998 Mar; 164(3):173-8. PubMed ID: 9562276
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TSH-receptor antibody (TSH-R Ab) variations in patients undergoing subtotal thyroidectomy for Graves' disease: a prospective study.
    Rubello D; Casara D; Pelizzo MR; Girelli ME; Piotto A; Piccolo M; Busnardo B
    J Nucl Biol Med (1991); 1993 Jun; 37(2):73-6. PubMed ID: 8373836
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Postoperative changes in thyrotropin-binding inhibitory immunoglobulin level in patients with Graves' disease: is subtotal thyroidectomy a suitable therapeutic option for patients of childbearing age with Graves' disease?
    Sugino K; Ito K; Ozaki O; Mimura T; Iwasaki H; Wada N
    World J Surg; 1999 Jul; 23(7):727-31. PubMed ID: 10390595
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thyroid autoantibody profiles in ophthalmic dominant and thyroid dominant Graves' disease differ and suggest ophthalmopathy is a multiantigenic disease.
    Goh SY; Ho SC; Seah LL; Fong KS; Khoo DH
    Clin Endocrinol (Oxf); 2004 May; 60(5):600-7. PubMed ID: 15104563
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The efficacy of thyroidectomy for Graves' disease: A meta-analysis.
    Palit TK; Miller CC; Miltenburg DM
    J Surg Res; 2000 May; 90(2):161-5. PubMed ID: 10792958
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Total thyroidectomy replaces subtotal thyroidectomy as the preferred surgical treatment for Graves' disease.
    Ku CF; Lo CY; Chan WF; Kung AW; Lam KS
    ANZ J Surg; 2005 Jul; 75(7):528-31. PubMed ID: 15972039
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term follow-up study of radioiodine treatment of hyperthyroidism.
    Metso S; Jaatinen P; Huhtala H; Luukkaala T; Oksala H; Salmi J
    Clin Endocrinol (Oxf); 2004 Nov; 61(5):641-8. PubMed ID: 15521969
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment outcome of Graves' disease in Thai children.
    Somnuke PH; Pusuwan P; Likitmaskul S; Santiprabhob J; Sawathiparnich P
    J Med Assoc Thai; 2007 Sep; 90(9):1815-20. PubMed ID: 17957924
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Postoperative course and tactics of aftercare in hyperthyroidism].
    de Heer K; Schnippenkoetter I; Kortmann KB; Beeger R
    Chirurg; 1984 Mar; 55(3):171-3. PubMed ID: 6546914
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factors affecting thyroid function after subtotal thyroidectomy for Graves' disease: case control study by remnant-weight matched-pair analysis.
    Ozaki O; Ito K; Mimura T; Sugino K; Ito K
    Thyroid; 1997 Aug; 7(4):555-9. PubMed ID: 9292942
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relevance of TSH receptor stimulating and blocking autoantibody measurement for the prediction of relapse in Graves' disease.
    Schott M; Minich WB; Willenberg HS; Papewalis C; Seissler J; Feldkamp J; Bergmann A; Scherbaum WA; Morgenthaler NG
    Horm Metab Res; 2005 Dec; 37(12):741-4. PubMed ID: 16372227
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical results of anti-inflammatory therapy in Graves' ophthalmopathy and association with thyroidal autoantibodies.
    Eckstein AK; Plicht M; Lax H; Hirche H; Quadbeck B; Mann K; Steuhl KP; Esser J; Morgenthaler NG
    Clin Endocrinol (Oxf); 2004 Nov; 61(5):612-8. PubMed ID: 15521965
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thyroidectomy remains an effective treatment option for Graves' disease.
    Weber KJ; Solorzano CC; Lee JK; Gaffud MJ; Prinz RA
    Am J Surg; 2006 Mar; 191(3):400-5. PubMed ID: 16490555
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Long-term evolution of immunologic and thyroid function in Graves disease according different therapeutic options].
    Campos Pastor MM; Fernández Soto ML; Escobar-Jiménez F; Barredo Acedo F; Ruiz de Almodóvar M
    Med Clin (Barc); 1994 Apr; 102(12):446-50. PubMed ID: 7516033
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preoperative change of thyroid stimulating hormone receptor antibody level: possible marker for predicting recurrent hyperthyroidism in patients with Graves' disease after subtotal thyroidectomy.
    Sugino K; Mimura T; Ozaki O; Iwasaki H; Wada N; Matsumoto A; Ito K
    World J Surg; 1996 Sep; 20(7):801-6; discussion 806-7. PubMed ID: 8678954
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Significance of values of thyrotropin binding inhibitor immunoglobulins and appearance of intrathyroidal lymphocytes at subtotal thyroidectomy for Graves' disease.
    Kasuga Y; Sugenoya A; Kobayashi S; Shimizu T; Onuma H; Shingu K; Asanuma K; Hama Y; Iida F
    J Am Coll Surg; 1994 Jun; 178(6):589-94. PubMed ID: 7910771
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thyroidectomy for Graves' disease: is hypothyroidism inevitable?
    Davenport M; Talbot CH
    Ann R Coll Surg Engl; 1989 Mar; 71(2):87-91. PubMed ID: 2705732
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Serum thyrotropin binding inhibitory immunoglobulin (TBII) activity before and after subtotal thyroidectomy in Grave's disease].
    Hoshi T; Watanabe I; Endo S
    Nihon Geka Gakkai Zasshi; 1985 Nov; 86(11):1538-45. PubMed ID: 2867461
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Natural course of Graves' disease after subtotal thyroidectomy and management of patients with postoperative thyroid dysfunction.
    Kuma K; Matsuzuka F; Kobayashi A; Hirai K; Fukata S; Tamai H; Miyauci A; Sugawara M
    Am J Med Sci; 1991 Jul; 302(1):8-12. PubMed ID: 1676563
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Extensive thyroidectomy in Graves' disease.
    Gaujoux S; Leenhardt L; Trésallet C; Rouxel A; Hoang C; Jublanc C; Chigot JP; Menegaux F
    J Am Coll Surg; 2006 Jun; 202(6):868-73. PubMed ID: 16735199
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.